Indo US Bio-Tech Share Price

Indo US Bio-Tech (INR)282.35-13.2   (-4.5%)

Exchange ScripsBSE541304NSEINDOUSISININE250Z01010

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Indo US Bio-Tech Performance

Market performance
Open price293
High299.5
Volumes25479
Prev Close282.35
Low280
Closing date2024-12-05
Historical performance
1 Year High331.80
3 Year High331.80
5 Year High331.80
1 Year Low222.00
3 Year Low222.00
5 Year Low222.00

Indo US Bio-Tech Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
0
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
102.23
Dividend Yield
Dividend Yield
N/A

Indo US Bio-Tech Investment Returns

1 Year
N/A
3 Years
N/A
5 Years
N/A
10 Years
N/A

Indo US Bio-Tech Technicals

IndicatorsValueSignal
5-DMA291.64Bearish
10-DMA273.77Bullish
20-DMA259.64Bullish
50-DMA
100-DMA
200-DMA

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters77755
Foreign Investors---------------
Domestic Investors77755
Public Investors966112611591222313
Government---------------

Indo US Bio-Tech Financials

Below figures are in Rs. Crores

ParticularsMar-2022Mar-2021Mar-2020
Other Income2------
Operating Profit705440
Interest12129
Depreciation432
Profit Before Tax533929
Consolidated Net Profit514925
Adjusted EPS332

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2022Mar-2021Mar-2020
Share Capital926161
Total Reserves293153104
Minority Interest---------
Total Non-Current Liabilities444015
Total Liabilities552434347
Capital Work in Progress232013
Total Assets552434347

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2022Mar-2021Mar-2020
Cash Flow from Operating Activities272-8
Cash Flow from Investing Activities-54-18-6
Cash Flow from Financing Activitie271615
Net Cash Inflow / Outflow-1-11
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 102.23.
  • 3Y Stock Price CAGR of the stock is None.
  • The stock has a beta of 1.6.
  • In the last financial year, the company had an EBITDA of ₹70 Million.
  • The company generated revenue of ₹501 Million in the previous financial year.

Indo US Bio-Tech

282.35-13.2   (-4.5%)

Investment Amount: ₹ 29260
Current Value: ₹ 28235
Performence: -3.5%
P/L: ₹ -1025
Top Gainers
SymbolChange%
MANBA189.98(16%)
SAMBHAAV6.97(16%)
AKG21(15%)
LAMBODHARA195.61(14%)
BSE5194.9(14%)
Top Losers
SymbolChange%
GRAPHITE569.3(-6%)
KHADIM379.4(-6%)
NELCO1239.25(-5%)
SOMATEX57.06(-5%)
LIBERTSHOE476.25(-5%)
NBIFIN3617.05(-5%)
GENUSPOWER439.7(-5%)
20MICRONS257.16(-5%)
Similar stocks

Kaveri Seed

4.7

969.9

November 5 - December 5

Nath Bio-Genes

4.4

198.32

November 5 - December 5

Agri-Tech (India)

4.3

207.22

November 5 - December 5

Bombay Super Hybrid

2

164.99

November 5 - December 5

Narmada Agrobase

1.3

16.42

November 5 - December 5

Venkys India

-2.1

1791.35

November 5 - December 5

Mangalam Global Ent

-4.8

23.77

November 5 - December 5

Harrisons Malayalam

-5.5

259.55

November 5 - December 5

Announcing Stock of the Month!

Stock of the Month
Stock of the Month